Chronic myeloid leukemia (CML)
prognostic factors and survival analysis
Keywords:
Chronic Myeloid Leukemia, Philadelphia Chromosome, PrognosisAbstract
The prognostic value of different factors upon diagnosis of CML was analysed in 45 Philadelphia (Ph1)-positive patients. The median survival was 48 months. Univariate analysis showed 5 poor prognostic factors (male sex, under 45 years-old, bone marrow blasts greater than or equal to 10 percent, blood basophils greater than or equal to 6 percent and blood eosinophils greater than or equal to 6 percent) which provided for the development of a clinical staging system: Stage I with none or one factor and a two-year survival rate of 100 percent; Stage II with two or three factors and two-year survival of 72.2 percent; and Stage III with four or five factors and two-year survival of 0 percent (p = 0.00016). Multivariate survival analysis showed that combination of blood basophilia and bone marrow blasts had the strongest predictive relationship to survival time. We conclude that a combination of pretreatment factors identifies different risk subcategories in CML patients and is helpful in assessing the overall prognosis and the treatment approach.
Downloads
References
Alimena G, Morra E, Lazzarino M, et al. Interferon alfa-2b as therapy for patients with Ph 1-positive chronic myelogenous leukemia. Eur J Haematol 1990;45(52):25-8.
Cervantes F, Rozman C. A multivariate analysis of prognostic factors in chronic myeloid leukemia. Blood 1982;60:1298-1304.
Champlin RE, Golde DW. Chronic myeloid leukemia: recent advances. Blood 1985;65(5):1039-1047.
Cox RD. Regression models and life-tables. J R Stat Soc B 1982;34:187-202.
Ezdinli EZ, Sokal JE, Crosswhite BS, Sandberg AA. Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia. Ann Int Med 1970;7(2):175-182.
Fitzgerald PH, Beard EJ, Morris CM, Heaton DC, Reeve AE. Ph-negative chronic myeloid leukemia. Br J Haematol 1987;66:311-4.
Frisch B, Bartl R, Burkhardt R, Jager K, Mahl G, Kettner G. Classification of myeloproliferative disorders by bone marrow histology. Biblthca Haemat 1984;50:57-80.
Gomez A, Sokal JE, Walsh D. Prognostic features at diagnosis of chronic myelocytic leukemia. Cancer 1981;47:2470-7.
Janossy G, Woodruff RK, Pippard MJ, et al. Relation of lymphoid phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of CML Ph 1-positive leukemia. Cancer 1989;43:426-434.
Jootar S, Ongphiphaphadhanakul B, Chuncharunee S, Atichartakarn V. Multivariate analysis of prognostic factors in chronic myeloid leukemia. J Med Assoc Thai 1990;73(12):662-9.
Kantarjian MH, Smith TL, McCredie KB, et al. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood 1985;66(6):1326-1335.
Kaplan GL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
Lee ET. Statistical methods for survival data analysis. Lifetime Learning Publication. Belmont:Publication Lifetime Learning, 1980:551.
Rowley JD. The Philadelphia chromosome translocation: a paradigm for understanding leukemia. Cancer 1990;65(10):2178-2184.
Silver RT. Chronic myeloid leukemia: a perspective of the clinical and biologic issues of the chronic phase. Haematol/Oncol. Clin N Am 1990;4(2):319-335.
Sjogren U, Brandt L, Mieltman F. Relation between life expectancy and composition of the bone marrow at diagnosis of chronic myeloid leukemia. Scand J Haematol 1974;12:369-373.
Sokal JE, Baccarani M, Tura S, et al. Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance of bone marrow transplantation. Blood 1985;66(6):1352-7.
Sokal JE, Cox EB, Baccarani M, et al. and the Italian Cooperative CML Study Group. Prognostic discrimination in "good risk" chronic granulocytic leukemia. Blood 1984;63(4):789-799.
Theologides A. Unfavorable signs in patients with chronic myeloid leukemia. Ann Int Med 76:95-9.
Tura S, Baccarani M, Corbelli, G and the Italian Cooperative Study Group On Chronic Myeloid Leukemia. Staging of chronic myeloid leukemia. Br J Haematol 1981;47:105-119.
